Luis Miguel
Seijo Maceiras
Consultor Médico
Instituto Valenciano de Oncologia
Valencia, EspañaPublications in collaboration with researchers from Instituto Valenciano de Oncologia (1)
2023
-
Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients
Journal of Translational Medicine, Vol. 21, Núm. 1